Recent case law highlights enablement and written description challenges for genus claims. Given the challenges of enforcing genus claims, the doctrine of equivalents (DOE) may become a more important tool for patentees when...more
Many stakeholders in the AgTech industry are interested in collaborating with or obtaining funding from the United States Department of Agriculture (USDA), but are unsure what implications such collaborations may have on...more
China is considering new export restrictions on advanced technologies, including, in particular, in the life sciences sectors. In late December 2022, China’s Ministry of Commerce (“MOFCOM”) issued the proposed amendment to...more
3/23/2023
/ Biopharmaceutical ,
Biotechnology ,
China ,
CRISPR ,
DNA ,
Export Controls ,
Genetic Materials ,
Genetic Testing ,
Life Sciences ,
MInistry of Commerce ,
Technology